Skip to content

Effects of perineometer training on pelvic floor muscle strength in stress urinary incontinence

EFFECTS OF PERINEOMETER-GUIDED BIOFEEDBACK ON PELVIC FLOOR MUSCLE STRENGTH AND QUALITY OF LIFE IN STRESS URINARY INCONTINENCE: A RANDOMIZED CONTROL TRIAL - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077697
Enrollment
60
Registered
2024-12-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N393- Stress incontinence (female) (male)

Interventions

Intervention1: CONVENTIONAL GROUP: GROUP A Conventional Exercises Phases I Duration weeks 1 Breathing Exercise Deep Breathing Warmup Exercise PEMT in Supine with Legs Apart Strengthening for Ba

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women aged above 45 years, clinically diagnosed case of stress incontinence by obstetrics and gynecologist department. 2. Women of varying maternal parity, referring to those who have experienced different numbers of pregnancies and childbirths 3. Women who expressed a willingness to engage in various therapeutic modalities. 4. Participants who are hemodynamically stable, indicating that their cardiovascular parameters are within normal limits and do not show signs of significant instability. 5. The capacity to comprehend/ understand instructions and adhere to commands effectively. 6. Participants who have expressed their willingness to engage in the study, demonstrating an eagerness to contribute to the research process and the overall objectives of the investigation.

Exclusion criteria

Exclusion criteria: 1. Women using pharmacological agents that exacerbate urinary incontinence 2. Women presenting with advanced genital prolapse, characterized by significant descent of pelvic organs, resulting in potential complications related to urinary, bowel, and sexual function. 3. Women who have undergone surgical intervention for urogenital prolapse, which involves the repair of pelvic organ descent and aims to restore normal anatomical positioning, alleviate associated symptoms, and improve quality of life. 4. Individuals with any other orthopedic condition, encompassing a range of musculoskeletal disorders that may affect mobility, strength, or function, potentially impacting overall physical health and the ability to engage in therapeutic interventions. 5. participants diagnosed with neurological diseases, which encompass a variety of conditions affecting the central and peripheral nervous systems, potentially leading to impairments in motor function, cognitive abilities, and daily living activities, thereby complicating their overall health management and rehabilitation efforts. 6. participants diagnosed with uterine cancer, a malignancy originating in the lining of the uterus, which may present with various symptoms and complications, and often necessitates a comprehensive treatment approach including surgery, radiation, and/or chemotherapy, significantly impacting their physical health, emotional well-being, and quality of life. 7. participants exhibiting visual and perceptual deficits, including those with neglect syndrome, which involves a reduced awareness of one side of the visual field, leading to challenges in spatial orientation and interaction with their environment. These conditions can significantly affect daily functioning, cognitive processing, and overall quality of life, necessitating tailored therapeutic interventions to enhance rehabilitation outcomes.

Design outcomes

Primary

MeasureTime frame
Pelvic Muscle Strength Timepoint: week 0-week 4

Secondary

MeasureTime frame
King’s Health Questionnaire (KHQ)Timepoint: week 0 - week 4

Countries

India

Contacts

Public ContactDr Deepali Hande

Professor and Head of Department

deepali.hande@pmtpims.org8275034001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026